Adeno-associated viral gene therapy program based on the specific screen through its pyroptotic technology
Primecell’s immuno-oncology and immuno-infectious platform uses its proprietary pyroptosis technology to induce tumor cell and pathogen death via immune activation (innate and adaptive) with immune memory surveillance. Primecell has two technologies to induce indication specific pyroptosis: 1) Oncology – safely and efficiently deliver a pyroptotic inducing gene through viral intratumoral administration and an oral small…
Read more
